Mats Wahlstrom - Feb 25, 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Mats Wahlstrom
Stock symbol
CHRS
Transactions as of
Feb 25, 2022
Transactions value $
$178,934
Form type
4
Date filed
3/1/2022, 07:22 PM
Previous filing
Feb 11, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Award $116K +10K $11.64 10K Feb 25, 2022 Direct
transaction CHRS Common Stock Award $62.5K +30K +299.76% $2.08 40K Feb 28, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Options Exercise $0 +30K $0.00* 0 Feb 28, 2022 Common Stock 30K $2.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option are fully vested and exercisable.